Your session is about to expire
← Back to Search
IMRT +/− Cisplatin for Oropharyngeal Cancer
Study Summary
This trial is studying IMRT with or without cisplatin to see how well it works in treating patients with oropharyngeal cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread beyond its original site or I have swollen lymph nodes below my collarbone.I am fully active or restricted in physically strenuous activity but can do light work.My blood, kidney, and liver tests are normal.I have received chemotherapy for my current cancer.I am 18 years old or older.My cancer is p16 positive.I've had radiation in the same area as my current cancer.I have been diagnosed with squamous cell carcinoma in my throat.I had a throat exam using a special camera within the last 70 days.My cancer originates from the mouth, nose, throat, or voice box.My cancer has spread to the lymph nodes near my collarbone.I have not had any other cancer besides this one in the last 3 years.My cancer is in an early to mid-stage, not spread widely.I have more than one primary cancer or tumors in both sides of a body part.My cancer tissue has been tested for p16.I had surgery to remove all visible cancer from the primary and nodal sites.My cancer can be seen or measured on scans.
- Group 1: IMRT 5 weeks
- Group 2: IMRT 6 weeks + cisplatin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are some of the primary illnesses that Cisplatin is used to treat?
"Cisplatin is a go-to treatment for advanced ovarian cancer. However, it has also shown efficacy in treating refractory testicular cancer and other directives."
Are there many places in town where this clinical trial is happening?
"There are currently 100 patients enrolled in this clinical trial, with locations such as University Health Network-Princess Margaret Hospital in Toronto, UPMC-Heritage Valley Health System Beaver in Beaver, and NorthShore University HealthSystem-Glenbrook Hospital."
Are there short-term or long-term risks associated with Cisplatin?
"Cisplatin safety is estimated to be a 2. Although there is some clinical data supporting its safety, none of it points to the medication being effective."
How many people are allowed to enroll in this trial?
"This specific trial is not currently looking for new patients, as it was last edited on September 7th, 2022. However, there are 2798 other trials actively enrolling participants with stage ivb oropharyngeal squamous cell carcinoma and 714 trials for Cisplatin that are still recruiting."
Are patients able to sign up for this clinical trial at this time?
"This study is no longer recruiting patients. The last date for recruitment was September 7th, 2022. However, there are 2798 other trials actively recruiting participants with stage ivb oropharyngeal squamous cell carcinoma and 714 trials for Cisplatin that may be of interest."
Is this the first time Cisplatin has been used in a research setting?
"There are over seven-hundred clinical trials currently underway researching Cisplatin. Just under three-hundred of these live trials are in Phase 3. The majority of studies for Cisplatin are based in Shanghai, but there are 43259 locations running trials for this treatment globally."
Share this study with friends
Copy Link
Messenger